We found that expression levels of four genes, namely Chymase, FCGR1A, KIT, and PGD2 synthase, demonstrated no significant differences between normal lymph nodes and lymph nodes (HN0) when compared to lymph nodes with overt metastatic disease (HN3). This evidence concerns the gene CMA1 and metastatic neoplasm.